Introduction: Mesenchymal stromal cells (MSCs) are undifferentiated cells with high proliferation potency. These cells can be
characterized by their ability to self-renew and differentiate into specialized cell lineages. Therefore, these cells are considered as an
attractive source of stem cells for cell therapy. However, MSCs are slightly different from different sources. The most used stem cell types, in both human and veterinary fields, are MSC derived from bone marrow and adipose tissue. Nowadays, there is a great
interest in using stem cells derived from fetal tissues, such as decidua, which can be obtained non-invasively at delivery time and are
an unlimited source of stromal cells. Materials and methods: In this study, biological characteristics of stromal cells from adipose
tissue (AT-MSC), bone marrow (BM_MSCs), and decidua (DSC), such as proliferation capacity, passage capacity, colony formation
and cell viability after cryopreservation were compared. Results: Based on our results, population doubling time of DSC in
comparison with BM_MSC and AT-MSC is shorter (under 20 hours to passage 10), and these cells possess the highest potential in
colony formation and ability of self-renewal. Also, these cells were well-maintained their viability after Cryopreservation up to 80%.
Conclusion: DSCs have higher colony-forming ability and long-time passage capacity. Due to the significant proliferation capacity
and great viability after cryopreservation, DSCs may be considered as a new source of stromal cells for application in cell-based
therapies.
Keywords: Mesenchymal stem cell, Decidua, Cryopreservation, Proliferation capacity, Colony formation.